Actions of adenosine at its receptors in the CNS: Insights from knockouts and drugs

被引：282

作者：

Fredholm, BB ^{[1
]}

Chen, JF

Masino, SA

Vaugeois, JM

机构：

[1] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden

[2] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA

[3] Trinity Coll, Dept Psychol, Hartford, CT 06106 USA

[4] Trinity Coll, Neurosci Program, Hartford, CT 06106 USA

[5] Fac Med & Pharm, CNRS, FRE2735, IFRMP 23, F-76183 Rouen, France

来源：

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY | 2005年 / 45卷

关键词：

A1; receptor; A2A receptor; caffeine; ischemia; Parkinson's disease; pain;

D O I：

10.1146/annurev.pharmtox.45.120403.095731

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Adenosine and its receptors have been the topic of many recent reviews (1-26). These reviews provide a good summary of much of the relevant literature-including the older literature. We have, therefore, chosen to focus the present review on the insights gained from recent studies on genetically modified mice, particularly with respect to the function of adenosine receptors and their potential as therapeutic targets. The information gained from studies of drug effects is discussed in this context, and discrepancies between genetic and pharmacological results are highlighted.

引用

页码：385 / 412

页数：28

共 158 条

[1] Aggravated brain damage after hypoxic ischemia in immature adenosine A2A knockout mice [J].

Ådén, U ;

Halldner, L ;

Lagercrantz, H ;

Dalmau, I ;

Ledent, C ;

Fredholm, BB .

STROKE, 2003, 34 (03) :739-744

[2] Adenosine kinase and 5′-nucleotidase activity after prolonged wakefulness in the cortex and the basal forebrain of rat [J].

Alanko, L ;

Heiskanen, S ;

Stenberg, D ;

Porkka-Heiskanen, T .

NEUROCHEMISTRY INTERNATIONAL, 2003, 42 (06) :449-454

[3]

Alfinito PD, 2003, J NEUROSCI, V23, P10982

[4] Purinergic P2 receptors trigger adenosine release leading to adenosine A2A receptor activation and facilitation of long-term potentiation in rat hippocampal slices [J].

Almeida, T ;

Rodrigues, RJ ;

De Mendonça, A ;

Ribeiro, JA ;

Cunha, RA .

NEUROSCIENCE, 2003, 122 (01) :111-121

[5] Association between A2a receptor gene polymorphisms and caffeine-induced anxiety [J].

Alsene, K ;

Deckert, J ;

Sand, P ;

de Wit, H .

NEUROPSYCHOPHARMACOLOGY, 2003, 28 (09) :1694-1702

[6] Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist [J].

Aoyama, S ;

Kase, H ;

Borrelli, E .

JOURNAL OF NEUROSCIENCE, 2000, 20 (15) :5848-5852

[7] Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling [J].

Apasov, SG ;

Blackburn, MR ;

Kellems, RE ;

Smith, PT ;

Sitkovsky, MV .

JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (01) :131-141

[8] Gene dose effect reveals no Gs-coupled A2A adenosine receptor reserve in murine T-lymphocytes:: studies of cells from A2A-receptor-gene-deficient mice [J].

Armstrong, JM ;

Chen, JF ;

Schwarzschild, MA ;

Apasov, S ;

Smith, PT ;

Caldwell, C ;

Chen, P ;

Figler, H ;

Sullivan, G ;

Fink, S ;

Linden, J ;

Sitkovsky, M .

BIOCHEMICAL JOURNAL, 2001, 354 :123-130

[9] Caffeine, postmenopausal estrogen, and risk of Parkinson's disease [J].

Ascherio, A ;

Chen, H ;

Schwarzschild, MA ;

Zhang, SM ;

Colditz, GA ;

Speizer, FE .

NEUROLOGY, 2003, 60 (05) :790-795

[10] Prospective study of caffeine consumption and risk of Parkinson's disease in men and women [J].

Ascherio, A ;

Zhang, SMM ;

Hernán, MA ;

Kawachi, I ;

Colditz, GA ;

Speizer, FE ;

Willett, WC .

ANNALS OF NEUROLOGY, 2001, 50 (01) :56-63

← 1 2 3 4 5 6 7 8 9 10 →